ECT and delirium in Parkinson's disease.
Zervas
I M
IM
Fink
M
M
D000978:Antiparkinson Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D003693:Delirium / Q000209:etiology*; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000628:therapy; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy
D000978:Antiparkinson Agents